Emrick Pharmaceuticals Private Limited
About Emrick Pharmaceuticals Private Limited
Data last updated:
Emrick Pharmaceuticals Private Limited is a private limited company based in Bulandshahr, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24232UP2012PTC233442. Its GSTIN is 09AADCE4663M1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Saba Khan and Mohd Javed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bulandshahr, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.25 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹36,423 (net margin -1%) and EBITDA of ₹1.83 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹13 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor 93 Sushila Vihar – 1, Delhi Road Bhoor, Bulandshahr, Uttar Pradesh, India – 203001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Emrick Pharmaceuticals Private Limited
Emrick Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232DL2012PTC241840. The current CIN is U24232UP2012PTC233442, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232UP2012PTC233442 | Current |
| U24232DL2012PTC241840 | Previous |
Business Activity of Emrick Pharmaceuticals Private Limited
The main business activity of Emrick Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Emrick Pharmaceuticals Private Limited
Emrick Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saba Khan | Director | 07 Sep 2012 | 14 Years 0 Months | Current |
| Mohd Javed | Director | 07 Sep 2012 | 14 Years 0 Months | Current |
Financials of Emrick Pharmaceuticals Private Limited FY 2025 filings available
Emrick Pharmaceuticals Private Limited reported revenue of ₹38.25 Lakh (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Emrick Pharmaceuticals Private Limited
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emrick Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.83 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹36,423 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Emrick Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emrick Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emrick Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2021 | Canara Bank | ₹13 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Emrick Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Emrick Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Emrick Pharmaceuticals Private Limited
Emrick Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCE4663M1Z7 | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Emrick Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emrick Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emrick Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emrick Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Emrick Pharmaceuticals Private Limited
Frequently Asked Questions about Emrick Pharmaceuticals Private Limited
Emrick Pharmaceuticals is an active private limited company based in Bulandshahr, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2012 (14+ years old) and is registered under CIN U24232UP2012PTC233442.
Emrick Pharmaceuticals reported revenue of ₹38.25 Lakh for FY 2025 (down 18% YoY).
Emrick Pharmaceuticals has 2 current directors:
- Saba Khan - Director
- Mohd Javed - Director
Emrick Pharmaceuticals reported a net loss of ₹36,423 (net margin -1%) and EBITDA of ₹1.83 Lakh (EBITDA margin 4.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emrick Pharmaceuticals is -2% over three years and 8% over five years. In the latest year (FY 2025) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Emrick Pharmaceuticals is 09AADCE4663M1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Emrick Pharmaceuticals is U24232UP2012PTC233442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emrick Pharmaceuticals was incorporated on 07 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The registered office of Emrick Pharmaceuticals is at Ground Floor 93 Sushila Vihar – 1, Delhi Road Bhoor, Bulandshahr, Uttar Pradesh, India – 203001.